Moderna's AI-designed mRNA cancer vaccine succeeds in Phase 3 trial
Scobleizer · x · 2026-08-20
Moderna announced that an mRNA cancer vaccine designed using AI has succeeded in a Phase 3 clinical trial. This is considered a major breakthrough for AI in healthcare, signaling the technology's potential to accelerate cures for diseases, despite not yet being approved and serving currently as a treatment. The post also counters criticisms regarding AI's water usage and job displacement.
More from Apps
- Automate Family Clothing Shopping with Grok Bot Skills and Size Tracking — RachelVT42 · 2026-08-20
- H3 OOM Issues on RTX 4070 12GB Despite VRAM Clearing — Bananasutra · 2026-08-20
- Ecommerce Guide: Generate High-Converting Images with ChatGPT — GCWebDesigner · 2026-08-20
- Monument Valley Style: Prompt for Photo to 3D Minimalist Posters — GCWebDesigner · 2026-08-20
- GPT browser error tip: close tab to resume background task — doodlestein · 2026-08-20
- Grok Bot Demo: Automating Price Monitoring and Online Shopping — RachelVT42 · 2026-08-20